# XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)

NDC: 51662-1405
Generic name: XYLOCAINE(R) -MPF (LIDOCAINE HCI AND EPINEPHRINE)
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: EPIDURAL, INFILTRATION, INTRACAUDAL, PERINEURAL
Marketing started: 20191111

FDA application: NDA006488

## Active ingredients

- EPINEPHRINE BITARTRATE: .005 mg/mL
- LIDOCAINE HYDROCHLORIDE ANHYDROUS: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1405"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1405
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=971439ed-4507-7a30-e053-2a95a90a1f1c